Diagnostic Center for Disease

THE SEATTLE STUDY: Can repeat prostate biopsy be avoided by the use of a prostate nutritional formula

PRINCIPAL INVESTIGATOR:

Michael Brawer, M.D.

STUDY FORMAT:

A randomized, double blind, placebo controlled study

QUALIFICATION:

1. PSA level between 2.5 ng/ml and 15 ng/ml
2. A negative prostate biopsy
3. Digital rectal exam: inconsistent with prostate cancer

STUDY POPULATION:

A randomized trial with 20 patients in the placebo arm & 20 patients in the prostate nutritional arm

RECORD:

Original PSA reading that prompted the biopsy
PSA reading at 3 months - avoid ejaculation 48 hours prior
PSA reading at 6 months - avoid ejaculation 48 hours prior

NUTRITIONAL PRODUCT AND PLACEBO WILL BE SUPPLIED BY THE PROSTATITIS AND PROSTATE CANCER CENTER

STUDY SPONSOR: THE PROSTATITIS AND PROSTATE CANCER CENTER

STUDY IS COMPLETED AT THIS POINT

OPTIONAL DATA COLLECTION:

AUA symptom score - performed by the same investigator: EPS - performed by the same investigator